Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-19-016 from the NIH Guide for Grants and Contracts. The FOA will focus on fusion oncoproteins found in tumors that have high risk of treatment failure and for which there has been little progress in identifying targeted agents. Responsive applications can focus on any fusion oncoprotein in pediatric solid tumors or on NUP98 fusion proteins that occur in young children with acute myelogenous leukemia (AML). However, greater preference will be given to applications focused on PAX-FOXO (alveolar rhabdomyosarcoma), C11orf95RELA (ependymoma), or NUP98 fusion proteins. (Source: NIH Funding Opportuni...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 11, 2018 Category: Research Source Type: funding

Roche Translational & Clinical Research Center Request for Proposals for Young Investigator Award
Roche Translational & Clinical Research Center Request for Proposals for Young Investigator Award Roche is pleased to announce that we are accepting applications for the 2013 TCRC Young Investigators Award.  The awards are intended to provide support for the earlier stages of scientific research career development, so they are to be awarded to the employing institutions of promising emerging researchers.  Proposals will be evaluated based on scientific merit and innovation of the projects proposed to be conducted using the awards. Four awards will be presented on Oct 1, 2013 during the scientific sym...
Source: ScanGrants feed - August 21, 2013 Category: Research Authors: Roche Source Type: funding

Aplastic Anemia & MDS International Foundation Research Grant Program
Aplastic Anemia & MDS International Foundation Research Grant Program The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to help researchers dedicated to the study of bone marrow failure advance the understanding and treatment of aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH).  For more than twenty years, AA&MDSIF has provided financial support to research that leads to new insights into the causes of the bone marrow failure and that leads to the development of new therapeutic approaches. Eligibility To be eligible to ap...
Source: ScanGrants feed - January 21, 2013 Category: Research Authors: Aplastic Anemia & MDS International Foundation Source Type: funding